drug access

Views & Analysis

Ensuring access: how to help patients seeking experimental t...

The impact of the debate on the Right-to-Try laws in the US and what needs to be done to improve access to innovative drugs.

Views & Analysis

Going beyond CSR to reach ‘the two billion’

Impact of putting access to medicine at the core of pharma businesses.

News

J&J jumps on the MFN pricing train

Johnson & Johnson is the latest pharma group to agree a Most-Favoured Nation (MFN) drug pricing deal with the Trump administration to avert tariffs.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Editor's Picks